Fino Payments Bank gets RBI approval to appoint Pratap Singh as MD & CEO
Fino Payments Bank · Banks
Key highlights
- RBI approved Mr. Pratap Singh as MD & CEO for three years from Nov 27, 2026 or earlier
- Appointment subject to Board and shareholder approvals; Mr. Singh will take charge soon
- Mr. Pratap Singh has 29+ years experience in retail, SME banking, and digital transformation
Original filing
Receipt Of RBI Approval For Appointment Of MD & CEO Of The Bank
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other management change filings this fortnight
- Management changeOrganic Recycling SystemsOrganic Recycling Systems Ltd Board approves ESOP scheme, investment, and guarantee enhancement
- Management changeManorama IndustriesManorama Industries Limited announces Q2 FY2027 financials and board decisions
- Management changeAbans Financial ServicesAbans Financial Services CEO Chintan Mehta resigns effective November 11, 2026
- Management changeCanara HSBC Life Insurance CompanyCanara HSBC Life Insurance appoints Mr Indu Swaroop as CFO effective 25 Nov 2026
- EPACK Prefab Technologies CFO Rahul Agarwal resigns effective November 09, 2026
- Prima Plastics Limited announces board meeting outcomes and appointments/resignation
Potential multibaggers · Q2 FY27
Potential multibaggers in Banks
on management's own guidance
- Canara BankGood growth2
- Capital SmallGood growth1
- AU Small FinanceGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.